PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | C0023895|liver disease |
| Sentences | 82 |
| PubMedID- 23227248 | Exclusion criteria were: (1) advanced cirrhosis; (2) hepatocellular carcinoma; (3) other causes of liver disease or mixed aetiologies; (4) human immunodeficiency virus infection; (5) previous treatment with antiviral therapy, immunosuppressive drugs and/or regular use of steatosis-inducing drugs, evaluated by interview; (6) active intravenous drug addiction. |
| PubMedID- 24801168 | As effective antifibrotic therapies are developed, these approaches could attenuate the rising surge of hepatocellular carcinoma associated with chronic liver disease. |
| PubMedID- 23903617 | Conclusions: chronic hepatitis c, followed by ethanol abuse and chronic hepatitis b were the leading causes of underlying chronic liver disease associated with hepatocellular carcinoma. |
| PubMedID- 25785178 | Comparison of the accuracy of dwi and ultrasonography in screening hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 23144154 | Interleukin-6 and oncostatin m are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker gp73. |
| PubMedID- 24927176 | Hepatitis c virus (hcv) infection causes chronic liver diseases leading to hepatocellular carcinoma (hcc) and liver failure. |
| PubMedID- 22167508 | Small (hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 t mri and multiphasic 64-multirow detector ct. |
| PubMedID- 22258434 | Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. |
| PubMedID- 22707881 | Status quo of chronic liver diseases, including hepatocellular carcinoma, in mongolia. |
| PubMedID- 26234231 | hepatocellular carcinoma in a patient with polycystic liver disease. |
| PubMedID- 26327775 | Resectability of hepatocellular carcinoma in patients with chronic liver disease is dramatically limited by the need to preserve sufficient remnant liver in order to avoid postoperative liver insufficiency. |
| PubMedID- 21472122 | Obi might contribute to the progression of liver fibrosis and hepatocellular carcinoma development in patients with chronic liver disease. |
| PubMedID- 23140577 | Hepatitis c virus (hcv) is a hepacivirus that causes chronic liver disease, leading to hepatocellular carcinoma, cirrhosis, and chronic hepatitis in about 3% of the world population. |
| PubMedID- 21874252 | Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 20592927 | For the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease, gadobenate dimeglumine-enhanced mri has demonstrated a higher sensitivity than has multidetector ct (mdct) for hccs (≤ 1 cm) (11) and gadobenate dimeglumine-enhanced mri has demonstrated a better diagnostic performance than ferucarbotran-enhanced mri (12). |
| PubMedID- 26389885 | The role of this polymorphism in liver pathology is further suggested by its association with increased risk of non-alcoholic steatohepatitis [17], liver cirrhosis [18], and hepatocellular carcinoma in patients with underlying liver disease [19,20]. |
| PubMedID- 19760361 | Background: excellent survival obtained with liver transplantation (lt) for limited hepatocellular carcinoma (hcc) in patients with chronic liver disease is still challenged by the increasing discrepancy between candidates and grafts available. |
| PubMedID- 21418304 | Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 26274335 | Association of nonalcoholic fatty liver disease (nafld) with hepatocellular carcinoma (hcc) in the united states from 2004 to 2009. |
| PubMedID- 22576780 | Background: non-alcoholic fatty liver disease (nafld) can lead to cirrhosis and hepatocellular carcinoma and is strongly associated with obesity and insulin resistance. |
| PubMedID- 23113141 | To date more than 370 million people are chronically infected with hbv worldwide, leading to chronic liver disease and development of hepatocellular carcinoma (hcc) in many cases. |
| PubMedID- 20589433 | Background: as is known for many types of human cancers, the hepatocellular carcinoma (hcc) associated with chronic liver disease shows an obvious multistage process of tumor progression. |
| PubMedID- 20956466 | This prospective study aimed to compare the diagnostic performance of (18)f-fluorocholine and (18)f-fdg for detecting and staging hepatocellular carcinoma (hcc) in patients with chronic liver disease and suspected liver nodules. |
| PubMedID- 23449255 | Chronic alcohol consumption is a leading cause of chronic liver disease worldwide, leading to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 25065095 | Benefit of double contrast mri in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases. |
| PubMedID- 24073300 | The characteristics and specific advantages of the procedure, especially for hepatocellular carcinoma (hcc) patients with chronic liver diseases, are reviewed and discussed in this paper. |
| PubMedID- 24112253 | Objective: to determine the frequency of development of hepatocellular carcinoma in patients with chronic liver disease secondary to hepatitis c who had achieved sustained virological response with interferon and ribavirin therapy. |
| PubMedID- 22869157 | This study was conducted to determine whether pnpla3 rs738409 snps affect development and prognosis of hepatocellular carcinoma (hcc) in patients with various liver diseases. |
| PubMedID- 26386160 | As this cohort ages, progressive hcv-related liver disease leading to cirrhosis and hepatocellular carcinoma (hcc) will place a significant burden on the healthcare system. |
| PubMedID- 26523271 | Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 26473344 | Nonalcoholic fatty liver disease (nafld) can lead to cirrhosis, hepatocellular carcinoma, and ultimately death. |
| PubMedID- 24632765 | Statin therapy seems to be related to a reduced risk for hepatocellular carcinoma in patients with chronic liver disease, but randomized data are lacking. |
| PubMedID- 26239358 | Further, 23 % of these patients, if untreated, will eventually develop hepatocellular carcinoma, the primary cause of liver disease induced mortality [7]. |
| PubMedID- 21545731 | Hcv infection is frequently associated with chronic liver diseases and development of hepatocellular carcinoma. |
| PubMedID- 23828743 | [6] as shown in different studies, nash is associated with increased liver-related mortality due to end-stage liver disease and/or development of hepatocellular carcinoma. |
| PubMedID- 25387451 | This study examined whether glycated hemoglobin a1c (hba1c) and chronic liver diseases are associated with hepatocellular carcinoma (hcc) risk in type 2 diabetic patients. |
| PubMedID- 26201636 | Purpose: metabolic syndrome (ms) is a group of recognized risk factors for the development of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 26456168 | Background: in japan, the prevalence of hepatocellular carcinoma (hcc) associated with nonviral liver disease, especially with nonalcoholic fatty liver disease (nafld-hcc) and alcoholic liver disease (ald-hcc), has been increasing. |
| PubMedID- 21920517 | Aim: to compare the diagnostic performances of gadoxetic acid-enhanced magnetic resonance imaging (mri) and multiphasic multidetector computed tomography (mdct) in the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 21139506 | Conclusions: administration of double dose of gd-eob-dtpa provided better arterial enhancement of hepatocellular carcinomas in patients with chronic liver disease, and also improved the lesion-liver contrast in hepatocyte-phase images in patients with child-pugh class b disease. |
| PubMedID- 23884757 | Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 21688080 | Open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study. |
| PubMedID- 26099526 | Background & aims: alcoholic steatohepatitis (ash) is the progressive form of alcoholic liver disease and may lead to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 26225191 | Liver resection (lr) for hepatocellular carcinoma (hcc) in patients with chronic liver disease (cld) is associated with high risks of developing significant postoperative complications and multicentric metachronous lesions, which can result in the need for repeated treatments. |
| PubMedID- 23901347 | Several lines of evidence suggest that obi is associated with progression of liver fibrosis and the development of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 26202505 | Purpose: to evaluate the value of measuring shear wave velocity evoked by acoustic radiation force impulse (vttq) for the risk assessment of hepatocellular carcinoma (hcc) development in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 22814828 | Objective: to examine if liver stiffness measured by magnetic resonance elastography (mre) is a risk factor for hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 20227190 | For hepatocellular carcinoma, most often without underlying liver disease in children of the western world, results of resection with partial hepatectomy remain dismal, due to a high rate of recurrence. |
| PubMedID- 21667042 | Important exclusion criteria were decompensated liver disease or evidence of hepatocellular carcinoma (based on liver biopsy within the previous 2 years), coinfection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv) and current or near future pregnancy. |
| PubMedID- 20619382 | Background: hepatitis c virus (hcv) causes chronic liver disease that often leads to cirrhosis and hepatocellular carcinoma. |
Page: 1 2